The first concurrent detection of mitochondrial DNA m.3243A>G mutation, deletion, and depletion in a family with mitochondrial diabetes.


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
07 2020
Historique:
received: 11 01 2020
revised: 09 04 2020
accepted: 13 04 2020
pubmed: 13 5 2020
medline: 1 5 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

Mitochondrial diabetes (MD) is a rare monogenic form of diabetes and divided into type l and type 2. It is characterized by a strong familial clustering of diabetes with the presence of maternal transmission in conjunction with bilateral hearing impairment in most of the carriers. The most common form of MD is associated with the m.3243A>G mutation in the mitochondrial MT-TL1, but there are also association with a range of other point mutations, deletion, and depletion in mtDNA. The mitochondrial genome anomalies were investigated in a family with clinical features of MD, which includes a proband presenting severe MD conditions including cardiomyopathy, retinopathy, and psychomotor retardation. By investigating the patient's blood leukocytes and skeletal muscle, we identified the m.3243A>G mutation in heteroplasmic state. This mutation was absent in the rest of the family members. In addition, our analysis revealed in the proband a large mtDNA heteroplasmic deletion (~1 kb) and a reduction in mtDNA copy number. Our study points out, for the first time, a severe phenotypic expression of the m.3243A>G point mutation in association with mtDNA deletion and depletion in MD.

Sections du résumé

BACKGROUND
Mitochondrial diabetes (MD) is a rare monogenic form of diabetes and divided into type l and type 2. It is characterized by a strong familial clustering of diabetes with the presence of maternal transmission in conjunction with bilateral hearing impairment in most of the carriers. The most common form of MD is associated with the m.3243A>G mutation in the mitochondrial MT-TL1, but there are also association with a range of other point mutations, deletion, and depletion in mtDNA.
METHODS
The mitochondrial genome anomalies were investigated in a family with clinical features of MD, which includes a proband presenting severe MD conditions including cardiomyopathy, retinopathy, and psychomotor retardation.
RESULTS
By investigating the patient's blood leukocytes and skeletal muscle, we identified the m.3243A>G mutation in heteroplasmic state. This mutation was absent in the rest of the family members. In addition, our analysis revealed in the proband a large mtDNA heteroplasmic deletion (~1 kb) and a reduction in mtDNA copy number.
CONCLUSION
Our study points out, for the first time, a severe phenotypic expression of the m.3243A>G point mutation in association with mtDNA deletion and depletion in MD.

Identifiants

pubmed: 32394641
doi: 10.1002/mgg3.1292
pmc: PMC7336730
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1292

Informations de copyright

© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

Références

Diabetes Res Clin Pract. 2003 Mar;59(3):207-17
pubmed: 12590018
Neuromuscul Disord. 1999 Jul;9(5):305-7
pubmed: 10407850
Nephrol Dial Transplant. 2005 Feb;20(2):336-41
pubmed: 15585516
FEBS Lett. 1998 Aug 21;433(3):269-74
pubmed: 9744809
Genes Chromosomes Cancer. 2006 Aug;45(8):770-80
pubmed: 16708351
Diabet Med. 2008 Apr;25(4):383-99
pubmed: 18294221
PLoS Genet. 2014 Oct 09;10(10):e1004670
pubmed: 25299061
Nucleic Acids Res. 1998 Feb 15;26(4):967-73
pubmed: 9461455
Acta Diabetol. 1999 Sep;36(3):163-7
pubmed: 10664322
J Med Genet. 2007 Jan;44(1):69-74
pubmed: 16950816
Acta Myol. 2011 Jun;30(1):9-15
pubmed: 21842587
Neuron. 2014 Dec 17;84(6):1126-42
pubmed: 25521375
J Biomed Sci. 2008 Jul;15(4):535-43
pubmed: 18157618
Nat Metab. 2019 Oct;1(10):975-984
pubmed: 31950102
Biochem Biophys Res Commun. 2013 Feb 22;431(4):670-4
pubmed: 23357420
J Med Genet. 2006 Aug;43(8):671-7
pubmed: 16490799
J Diabetes Complications. 2010 Jul-Aug;24(4):270-7
pubmed: 20045353
Biotechniques. 1992 Oct;13(4):522-4
pubmed: 1476717
Chin Med J (Engl). 2004 Jul;117(7):985-9
pubmed: 15265369
J Biol Chem. 2005 Aug 5;280(31):28785-91
pubmed: 15946949
Nucleic Acids Res. 1999 Feb 1;27(3):756-63
pubmed: 9889270
JAMA. 2002 Nov 27;288(20):2579-88
pubmed: 12444865
Biochem Biophys Res Commun. 2015 Apr 10;459(3):353-60
pubmed: 25701779
Biochem Biophys Res Commun. 2011 Apr 22;407(4):747-52
pubmed: 21447323
Cells. 2019 Jan 29;8(2):
pubmed: 30700008
Exp Clin Endocrinol Diabetes. 2001;109(5):283-7
pubmed: 11507652
Brain. 2005 Aug;128(Pt 8):1861-9
pubmed: 15857931
Biochemistry. 2003 Feb 4;42(4):958-64
pubmed: 12549915
Mitochondrial DNA A DNA Mapp Seq Anal. 2016 Jul;27(4):2873-80
pubmed: 26258512
Cells. 2019 Jun 18;8(6):
pubmed: 31216686
Science. 2004 Nov 12;306(5699):1190-4
pubmed: 15498972
Microbiol Mol Biol Rev. 2013 Sep;77(3):476-96
pubmed: 24006472
Curr Protoc Hum Genet. 2011 Jan;Chapter 19:Unit 19.7.
pubmed: 21234878
Hum Mutat. 2005 Jun;25(6):575-82
pubmed: 15880407
Med Hypothesis Discov Innov Ophthalmol. 2017 Summer;6(2):30-38
pubmed: 29367932
Clin Endocrinol (Oxf). 2000 May;52(5):557-64
pubmed: 10792334
Tunis Med. 2010 Sep;88(9):642-5
pubmed: 20812177
Biochim Biophys Acta. 2009 Dec;1792(12):1097-102
pubmed: 19303927
Ann Med. 2005;37(3):213-21
pubmed: 16019720
J Neurol. 2014 Mar;261(3):504-10
pubmed: 24375076
Arch Physiol Biochem. 2002 Jul;110(3):186-8
pubmed: 12221518
Nat Genet. 1992 Apr;1(1):11-5
pubmed: 1301992
Diabetes. 2004 Feb;53 Suppl 1:S103-9
pubmed: 14749274
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195723
Biochem Biophys Res Commun. 2007 Apr 20;355(4):1031-7
pubmed: 17336924
Muscle Nerve. 1996 Feb;19(2):187-90
pubmed: 8559168
Arch Ophthalmol. 2008 Mar;126(3):320-8
pubmed: 18332310
Eur J Hum Genet. 2014 Aug;22(8):1040-5
pubmed: 24448545
Mol Genet Genomic Med. 2020 Jul;8(7):e1292
pubmed: 32394641
Am J Clin Pathol. 2006 Oct;126(4):593-601
pubmed: 16938655
J Diabetes Complications. 2017 Jan;31(1):253-259
pubmed: 27422531
BBA Clin. 2016 Apr 29;6:19-24
pubmed: 27331024
J Neurol Sci. 1996 Jan;135(1):81-4
pubmed: 8926502
Ann Intern Med. 2001 May 1;134(9 Pt 1):721-8
pubmed: 11329229

Auteurs

Mouna Tabebi (M)

Molecular and Functional Genetics Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.
Human Molecular Genetics Laboratory, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia.

Wajdi Safi (W)

Department of Endocrinology Diabetology, CHU Hedi Chaker, Sfax, Tunisia.

Rahma Felhi (R)

Molecular and Functional Genetics Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.

Olfa Alila Fersi (O)

Molecular and Functional Genetics Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.

Leila Keskes (L)

Human Molecular Genetics Laboratory, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia.

Mohamed Abid (M)

Department of Endocrinology Diabetology, CHU Hedi Chaker, Sfax, Tunisia.

Mouna Mnif (M)

Department of Endocrinology Diabetology, CHU Hedi Chaker, Sfax, Tunisia.

Faiza Fakhfakh (F)

Molecular and Functional Genetics Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH